Jay Harper

2.2k citations
36 papers · 1.5k · h-index 19

Impact in

  • Oncology top 5%
    • HER2/EGFR in Cancer Research
    • Peptidase Inhibition and Analysis
    • CAR-T cell therapy research
    • Protease and Inhibitor Mechanisms
    • Cancer, Hypoxia, and Metabolism

Papers in

    • Angiogenesis and VEGF in Cancer 7
    • Cancer therapeutics and mechanisms 4
    • Chemical Synthesis and Analysis 3
    • HER2/EGFR in Cancer Research 6

Jay Harper

33 papers receiving 1.4k citations

Peers

Jay Harper
Comparison fields: 5 of 96
  • Oncology 657
  • Cancer Research 337
  • Immunology and Allergy 110
  • Radiology, Nuclear Medicine and Imaging 273
  • Molecular Biology 663
Replace Sandra L. Biroc with:
Sandra L. Biroc United States
Antonella Zannetti Italy
Rebecca G. Bagley United States
Alessandra Villa Switzerland
Eric A. Murphy United States
Chisato M. Yamazaki Japan
Taturo Udagawa United States
Sven Christian Germany
Ngee Han Lim United Kingdom
Jan Olaf Stracke Switzerland
Jay Harper relative to Sandra L. Biroc United States Sandra L. Biroc's profile →
Citations per field
00.5×1.5×2×
Sandra L. Biroc · 1×
Citations per year

Countries citing papers authored by Jay Harper

Since Specialization
Citations

This map shows the geographic impact of Jay Harper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay Harper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay Harper more than expected).

Fields of papers citing papers by Jay Harper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jay Harper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay Harper. The network helps show where Jay Harper may publish in the future.

Co-authors

The 25 scholars most cited alongside Jay Harper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jay Harper Line = papers co-authored together Jay Harper links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2000339
2 2015111
3 2017103
4 2009100
5 200999
6 201893
7 200680
8 201278
9 200170
10 201157
11 200745
12 201534
13 201332
14 201928
15 201923
16 198620
17 201919
18 201919
19 201718
20 201815

About Jay Harper

Jay Harper is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Radiology, Nuclear Medicine and Imaging and Cancer Research, having authored 36 papers that have together received 1.5k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (8 papers), Angiogenesis and VEGF in Cancer (7 papers), HER2/EGFR in Cancer Research (6 papers), Synthesis and pharmacology of benzodiazepine derivatives (6 papers), Click Chemistry and Applications (4 papers), Cancer therapeutics and mechanisms (4 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Chemical Synthesis and Analysis (3 papers). The work is most often cited by research in Oncology (657 citations), Cancer Research (337 citations), Immunology and Allergy (110 citations), Radiology, Nuclear Medicine and Imaging (273 citations) and Molecular Biology (663 citations). Jay Harper has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Marsha A. Moses, Jianmin Fang, Catherine Butterfield, Yan Li, Dmitri Wiederschain, George S. Tamvakopoulos, Yuen Shing, Geraldine Jackson, Shenlan Mao and Michael Klagsbrun. Their work appears in journals such as Cancer Research, Molecular Cancer Therapeutics, Bioconjugate Chemistry, Clinical Cancer Research and European Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact